Citius Pharmaceuticals Inc. Common (CTXR) is a publicly traded Healthcare sector company. As of September 22, 2026, CTXR trades at $0.58 with a market cap of $16.47M and a P/E ratio of -0.33. CTXR moved -3.70% today. Year to date, CTXR is -25.80%; over the trailing twelve months it is -51.55%. Its 52-week range spans $0.47 to $3.05. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces CTXR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for CTXR, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $0.58 |
| Market Cap | $16.47M |
| P/E Ratio | -0.33 |
| EPS | $-1.78 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.05 |
| 52-Week Low | $0.47 |
| Volume | 153.42K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.11M |
| Net Income | $-58.17M |
| Gross Margin | 0.00% |
1 analysts cover CTXR: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.